HLVX
Price
$2.17
Change
+$0.08 (+3.83%)
Updated
Jul 14 closing price
Capitalization
108.72M
23 days until earnings call
LYRA
Price
$8.39
Change
-$0.32 (-3.67%)
Updated
Jul 15, 11:39 AM (EDT)
Capitalization
13.92M
28 days until earnings call
Interact to see
Advertisement

HLVX vs LYRA

Header iconHLVX vs LYRA Comparison
Open Charts HLVX vs LYRABanner chart's image
HilleVax
Price$2.17
Change+$0.08 (+3.83%)
Volume$237.5K
Capitalization108.72M
Lyra Therapeutics
Price$8.39
Change-$0.32 (-3.67%)
Volume$877
Capitalization13.92M
HLVX vs LYRA Comparison Chart in %
Loading...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLVX vs. LYRA commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLVX is a StrongBuy and LYRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 15, 2025
Stock price -- (HLVX: $2.17 vs. LYRA: $8.71)
Brand notoriety: HLVX and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HLVX: 79% vs. LYRA: 2%
Market capitalization -- HLVX: $108.72M vs. LYRA: $13.92M
HLVX [@Biotechnology] is valued at $108.72M. LYRA’s [@Biotechnology] market capitalization is $13.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLVX’s FA Score shows that 1 FA rating(s) are green whileLYRA’s FA Score has 0 green FA rating(s).

  • HLVX’s FA Score: 1 green, 4 red.
  • LYRA’s FA Score: 0 green, 5 red.
According to our system of comparison, HLVX is a better buy in the long-term than LYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLVX’s TA Score shows that 7 TA indicator(s) are bullish while LYRA’s TA Score has 3 bullish TA indicator(s).

  • HLVX’s TA Score: 7 bullish, 4 bearish.
  • LYRA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, HLVX is a better buy in the short-term than LYRA.

Price Growth

HLVX (@Biotechnology) experienced а +5.85% price change this week, while LYRA (@Biotechnology) price change was -3.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.48%. For the same industry, the average monthly price growth was +21.25%, and the average quarterly price growth was +31.32%.

Reported Earning Dates

HLVX is expected to report earnings on Nov 06, 2025.

LYRA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+10.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLVX($109M) has a higher market cap than LYRA($13.9M). HLVX YTD gains are higher at: 4.831 vs. LYRA (-15.601). LYRA has higher annual earnings (EBITDA): -44.7M vs. HLVX (-100.93M). HLVX has more cash in the bank: 160M vs. LYRA (31.7M). HLVX has less debt than LYRA: HLVX (24M) vs LYRA (33.4M). LYRA has higher revenues than HLVX: LYRA (1.19M) vs HLVX (0).
HLVXLYRAHLVX / LYRA
Capitalization109M13.9M784%
EBITDA-100.93M-44.7M226%
Gain YTD4.831-15.601-31%
P/E RatioN/AN/A-
Revenue01.19M-
Total Cash160M31.7M505%
Total Debt24M33.4M72%
TECHNICAL ANALYSIS
Technical Analysis
HLVXLYRA
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 14 days ago
83%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMXCF0.640.02
+2.87%
District Metals Corp.
CHUC0.09N/A
+1.53%
Charlie's Holdings, Inc.
CGXYY25.82N/A
N/A
China Galaxy Securities Co Ltd.
MDTWF2.15N/A
N/A
Mediterranean Towers LTD
NRXXY10.75N/A
N/A
NORDEX SE

HLVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLVX has been closely correlated with FBIOP. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if HLVX jumps, then FBIOP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLVX
1D Price
Change %
HLVX100%
+3.83%
FBIOP - HLVX
81%
Closely correlated
+0.50%
BRIBF - HLVX
55%
Loosely correlated
N/A
IPSC - HLVX
50%
Loosely correlated
-0.07%
CRSP - HLVX
50%
Loosely correlated
-0.67%
NTLA - HLVX
49%
Loosely correlated
+3.60%
More